SynthesisFrontiers in pharmacology2025

Efficacy and safety of tirabrutinib monotherapy in relapsed or refractory B-cell lymphomas/leukemia: a meta-analysis.

Jingfei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.